Kevin Flynn is a business executive, manager and operator with over 30 years of experience in value creation, strategy development and profit enhancement. His experience spans a broad array of financial and administrative activities and operational services in the areas of finance, taxation, revenue cycle, technology, human resources and organizational structuring, among other areas. Kevin has experience working with both established and start-up businesses, including privately held, venture-backed and publicly-owned entities... SEE MORE
Kevin began his career as a CPA in public accounting at Ernst & Young where he conducted audits of financial statements for manufacturing, service and distribution companies ranging from small privately-held ventures and non-profit entities to Units of Fortune 500-sized operations. This in-depth multi-year experience in public accounting has provided Kevin with a foundational understanding and intuitive sense of financial systems, organizational structures and problem resolution techniques.
Kevin continued his business career by joining an audit client as Controller with the challenge to restructure all organizational, financial, technology, administrative and operational systems of Neomedica, Inc. a healthcare service provider operating in a variety of medical spaces. After a successful restructuring, Kevin became CFO and he helped develop and manage a successful 10-year internal and external growth strategy. He then was lead negotiator in the sale of Neomelia for value of more than$100 million to Fresenius Medical Care NA, a unit of an international public company.
Kevin wolfed for the next five years as Midwest Regional Controller at Fresenius where he gained experience in working for a large public company. Fresenius divested its management arrangement with Associates in Nephrology, SC, the large nephrology practice supporting its Midwest operations, and Kevin accepted the position of CFO.
As CFO of AIN, Kevin managed all financial functions and led the practice's growth initiative by acquisition and service expansion. He managed the start-up of of three vascular access centers in 2012, Including one Ambulatory Surgery Center and he continued management of the vascular operations thereafter. Most notably, in 2015, Kevin also developed a 31-facility joint-venture with an initial value of $90 million in a leveraged financing arrangement with Fresenius. He successfully managed the joint-venture including executive oversight by participation from its inception on the joint-venture Management Committee. Kevin also was integrally involved in AIN's participation in the ESCO (ESRD Seamless Care Organization), the first value-based care program established by CMS beginning in 2017.
In 2020, Kevin left AIN and became Vice-President of Finance and Strategy for Oak Brook based Nephrology Associates of Northern Illinois and Indiana (NANI), a nephrology practice competitive to AIN and about three times larger. His initial senior management responsibilities included Clinical Research, Accounting, Finance and Revenue Cycle management. He also helped in new practice recruitment, acquired practice on-boarding and managed practice consulting. Within 6-months, Kevin was assigned additional senior management oversight for Human Resources, Information Technology and Value Based Care as Chairman of the VBC Finance Committee. He was instrumental in vetting and developing the framework for selecting NANI's population health management partner, Strive Health. He also was lead negotiator in valuation of the NANI KCE (Kidney Care Contracting Entities), in the sale of a 50% interest in the KCE's to Strive Health and in the sale of the Medicare Advantage rights of NANI to Strive Health. The Strive transactions exceeded an initial value of $30 million. In his VBC Finance role, Kevin designed a 10-point strategy to achieve the KCE's shared savings goals for 2022-26. In 2022, Kevin was admitted to the Renal Executive Forum, a national group of twenty-five thought leaders from large independent nephrology practices in the US. Kevin concluded his work commitment with NANI in November 2022.